20160128 EGA Regulatory and Scientific Affairs Conferenc

Generic Medicines save European Countries 100 Billion Euro per Year

28 September 2016

Lisbon, September 28, 2016 – Without the use of generic […]

Read more

Medicines for Europe and GPhA commit to supporting positive developments of the negotiations for a TTIP

23 September 2016

   Medicines for Europe and GPhA (Generic Pharmaceutical Association) are committed to […]

Read more

UN Meeting on Antimicrobial Resistance (AMR): Medicines for Europe engaged in addressing the Global Threat of AMR

22 September 2016

As a signatory of the Davos Declaration we welcome the […]

Read more

Fulfilling the Biosimilar Promise: Report Highlights Key Principles in Support of a Sustainable Market

19 September 2016

Biosimilar medicines provide a tremendous opportunity for governments throughout Europe […]

Read more

Industry Welcomes the European Commission Workshop on the Uptake of Biosimilar Medicines

20 June 2016

The European pharmaceutical industry welcomes the workshop organised today by […]

Read more

European Health Ministers Call for More Competition in Pharmaceutical Markets

17 June 2016

Medicines for Europe will engage rapidly with Health Ministers across […]

Read more

IGBA Joins ICH and Welcomes the Positive Vote of the General Assembly

15 June 2016

Read More

Biosimilar Medicines for Rheumatologists: Bridging the Gap between Regulatory Science and Medical Societies

10 June 2016

Over the past decade, biosimilar medicines have generated more than […]

Read more

Generic, Biosimilar and Value Added Medicines Industry Leaders Join Forces to Drive Access to Medicines Agenda

9 June 2016

During the next two days, the key pharmaceutical industry leaders […]

Read more

Value Added Medicines: Rethink, Reinvent & Optimise Medicines, Improving Patient Health & Access

31 May 2016

A new study Value Added Medicines: Rethink, Reinvent & Optimise […]

Read more

Subscribe to our newsletter

[contact-form-7 id="1638" title="Newsletter subscription"]